These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9501569)

  • 21. Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat.
    Stenina OI; Krukovets I; Wang K; Zhou Z; Forudi F; Penn MS; Topol EJ; Plow EF
    Circulation; 2003 Jul; 107(25):3209-15. PubMed ID: 12810612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diabetic complications in rats in long-term modeling of type I diabetes mellitus].
    Zakir'ianov AR; Plakhotniĭ MA; Onishchenko NA; Volodina AV; Klimenko ED; Kobozeva LP; Michuskaia AB; Pozdniakov OM
    Patol Fiziol Eksp Ter; 2007; (4):21-5. PubMed ID: 18154083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphoinositide 3-kinase mediated signalling contributes to development of diabetes-induced abnormal vascular reactivity of rat carotid artery.
    Yousif MH; Benter IF; Hares N; Canatan H; Akhtar S
    Cell Biochem Funct; 2006; 24(1):13-22. PubMed ID: 16130182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
    Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
    Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats.
    Ceylan A; Karasu C; Aktan F; Ozansoy G
    Diabetes Nutr Metab; 2004 Aug; 17(4):203-10. PubMed ID: 15575340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.
    Lawson SR; Gabra BH; Nantel F; Battistini B; Sirois P
    Eur J Pharmacol; 2005 May; 514(1):69-78. PubMed ID: 15878326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-level relationship for nitric oxide and the protective effects of aminoguanidine in experimental spinal cord injury.
    Soy O; Aslan O; Uzun H; Barut S; Iğdem AA; Belce A; Colak A
    Acta Neurochir (Wien); 2004 Dec; 146(12):1329-35; discussion 1335-6. PubMed ID: 15309585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluidising effect of resorcylidene aminoguanidine on sarcolemmal membranes in streptozotocin-diabetic rats: blunted adaptation of diabetic myocardium to Ca2+ overload.
    Waczulíková I; Ziegelhöffer A; Országhová Z; Cársky J
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 2):727-39. PubMed ID: 12510859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminoguanidine prevented impairment of blood antioxidant system in insulin-dependent diabetic rats.
    Stoppa GR; Cesquini M; Roman EA; Ogo SH; Torsoni MA
    Life Sci; 2006 Feb; 78(12):1352-61. PubMed ID: 16229859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of 2,5-dihydroxybenzylidene aminoguanidine on lipid oxidative damage and on antioxidant levels in model diabetes mellitus.
    Korytár P; Sivonová M; Maruniaková A; Ulicná O; Kvasnicka P; Liptáková A; Bozek P; Cársky J; Duracková Z
    Pharmazie; 2003 Oct; 58(10):733-7. PubMed ID: 14609287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of aminoguanidine upon capillary and submesothelial anionic sites.
    Shostak A; Wajsbrot V; Gotloib L
    Microvasc Res; 2001 Mar; 61(2):166-78. PubMed ID: 11254396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of hypertension development by aminoguanidine in spontaneously hypertensive rats: role of methylglyoxal.
    Wang X; Chang T; Jiang B; Desai K; Wu L
    Am J Hypertens; 2007 Jun; 20(6):629-36. PubMed ID: 17531919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
    Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
    Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the cannabinoid antagonist AM281 on systemic hemodynamics and mortality rate in streptozotocin-induced diabetic rats with endotoxic shock: comparison between non-diabetic and diabetic rats.
    Kadoi Y; Hinohara H; Kunimoto F; Saito S
    Acta Anaesthesiol Scand; 2008 May; 52(5):664-72. PubMed ID: 18261198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chronic chromium picolinate in animal models of anxiety and memory.
    Khanam R; Pillai KK
    Fundam Clin Pharmacol; 2007 Oct; 21(5):531-4. PubMed ID: 17868206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in vascular endothelial function in the aorta and mesenteric artery in type II diabetic rats.
    Matsumoto T; Wakabayashi K; Kobayashi T; Kamata K
    Can J Physiol Pharmacol; 2004 Mar; 82(3):175-82. PubMed ID: 15052283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental and clinical aspects of therapy of diabetes mellitus with guanidine derivatives].
    Mohnike G
    Wien Z Inn Med; 1965 Jul; 46(7):257-65. PubMed ID: 5319733
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversal of diabetes by intrapancreatic injection of aminoguanidine liposomes.
    Ricordi C; Behboo R; Klibanov A; Singal A; Huang L
    Transplant Proc; 1994 Dec; 26(6):3479. PubMed ID: 7998235
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell cycle regulators in vascular disease.
    MacLellan WR; Majesky MW
    Circulation; 1997 Sep; 96(6):1717-9. PubMed ID: 9323050
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of chronic treatment with aminoguanidine on vascular properties in diabetic rat models].
    Levy BI; Struyker Boudier H; Wolfenbuttel B
    Therapie; 1997; 52(5):419-22. PubMed ID: 9501569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.